AGP Picks
View all

Enlighten adds remote ePRO capabilities to its clinical trial platform

Nov. 2, 2026
By AI, Created 22:20 UTC, Nov 02, 2026, AGP -

Enlighten Clinical Solutions expanded its electronic patient-reported outcomes tools to let trial participants submit assessments remotely and make those responses available inside its connected data platform. The update is aimed at reducing manual transfers and helping sponsors, CROs, and sites review patient data faster.

Why it matters: - Electronic patient-reported outcomes can capture symptoms, functioning, and treatment experiences that may not surface during scheduled study visits. - Connecting those responses to clinical data systems can give research teams a more complete view of the participant experience. - The workflow can reduce separate tools, manual transfers, and administrative work across sponsors, CROs, and research sites.

What happened: - Enlighten Clinical Solutions announced expanded ePRO capabilities on November 2, 2026. - The new offering lets clinical trial participants complete study assessments remotely. - Participant responses flow into Enlighten's integrated Electronic Data Capture environment. - The company said the goal is to simplify how participants report experiences and how research teams collect and manage that data.

The details: - Patient-reported outcomes are designed to help study teams understand symptoms and daily functioning outside of site visits. - When participants complete electronic questionnaires, authorized study personnel can review the responses within the broader clinical data workflow. - The integrated setup can help teams identify when additional follow-up may be needed. - In a study where participants report symptoms between visits, electronic assessments can provide timely information without requiring an extra site trip. - Enlighten says the ePRO tools are part of a broader platform that also includes EDC, electronic Trial Master File, Clinical Trial Management System, and other study management tools. - The company says the platform is designed to support different protocols and study designs while keeping patient-reported data connected to other study information. - Enlighten's broader clinical trial platform is available at more information.

Between the lines: - The release frames ePRO as a workflow problem as much as a data collection feature. - By embedding patient input inside EDC, Enlighten is positioning the platform around fewer handoffs and more continuous review. - Jim Harris, founder and CEO of Enlighten Clinical Solutions, said study teams need to review and act on patient-reported data without adding a disconnected process. - Harris also said the company wants to make clinical trial information easier to manage as data comes from different people at different times.

What's next: - Enlighten says the expanded ePRO offering is part of continued investment in tools that reduce operational complexity and improve visibility across clinical trial activities. - Sponsors and CROs using the platform can expect more coordinated handling of patient-reported data alongside other trial records. - More information about the company’s platform is available at the company's announcement.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Global Business Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Business Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.